Insulin-like growth factor-II: New roles for an old actor

Stefano Cianfarani

doi:10.3389/fendo.2012.00118

Insulin-like growth factor-II: New roles for an old actor

Stefano Cianfarani

Ospedale Pediatrico Bambino Gesu

Research output: Contribution to journal › Article › peer-review

Abstract

Insulin-like growth factor-II (IGF-II), traditionally considered as a growth factor implicated in growth of fetal tissues and cancer cells, is now emerging as a potential metabolic regulator. The aim of this overview is to provide the available evidence, obtained in both experimen- tal conditions and in humans, for a role of IGF-II in the fine-tuning of metabolism and body composition. The underlying mechanisms and the potential clinical implications are discussed.

Original language	English
Article number	Article 118
Journal	Frontiers in Endocrinology
Volume	3
Issue number	OCT
DOIs	https://doi.org/10.3389/fendo.2012.00118
Publication status	Published - 2012

Keywords

Body composition
Insulin
Insulin receptor
Insulin-like growth factor I
Insulin-like growth factor II

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism

Access to Document

10.3389/fendo.2012.00118

Cite this

@article{c2741ea3ab294bac84ae1ce81ac59037,

title = "Insulin-like growth factor-II: New roles for an old actor",

abstract = "Insulin-like growth factor-II (IGF-II), traditionally considered as a growth factor implicated in growth of fetal tissues and cancer cells, is now emerging as a potential metabolic regulator. The aim of this overview is to provide the available evidence, obtained in both experimen- tal conditions and in humans, for a role of IGF-II in the fine-tuning of metabolism and body composition. The underlying mechanisms and the potential clinical implications are discussed.",

keywords = "Body composition, Insulin, Insulin receptor, Insulin-like growth factor I, Insulin-like growth factor II",

author = "Stefano Cianfarani",

year = "2012",

doi = "10.3389/fendo.2012.00118",

language = "English",

volume = "3",

journal = "Frontiers in Endocrinology",

issn = "1664-2392",

publisher = "Frontiers Media S. A.",

number = "OCT",

}

TY - JOUR

T1 - Insulin-like growth factor-II

T2 - New roles for an old actor

AU - Cianfarani, Stefano

PY - 2012

Y1 - 2012

N2 - Insulin-like growth factor-II (IGF-II), traditionally considered as a growth factor implicated in growth of fetal tissues and cancer cells, is now emerging as a potential metabolic regulator. The aim of this overview is to provide the available evidence, obtained in both experimen- tal conditions and in humans, for a role of IGF-II in the fine-tuning of metabolism and body composition. The underlying mechanisms and the potential clinical implications are discussed.

AB - Insulin-like growth factor-II (IGF-II), traditionally considered as a growth factor implicated in growth of fetal tissues and cancer cells, is now emerging as a potential metabolic regulator. The aim of this overview is to provide the available evidence, obtained in both experimen- tal conditions and in humans, for a role of IGF-II in the fine-tuning of metabolism and body composition. The underlying mechanisms and the potential clinical implications are discussed.

KW - Body composition

KW - Insulin

KW - Insulin receptor

KW - Insulin-like growth factor I

KW - Insulin-like growth factor II

UR - http://www.scopus.com/inward/record.url?scp=84874389954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874389954&partnerID=8YFLogxK

U2 - 10.3389/fendo.2012.00118

DO - 10.3389/fendo.2012.00118

M3 - Article

C2 - 23060858

AN - SCOPUS:84874389954

VL - 3

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

SN - 1664-2392

IS - OCT

M1 - Article 118

ER -

Insulin-like growth factor-II: New roles for an old actor

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this